RESUMEN
Endobronchial ultrasound (EBUS)-guided mediastinal cryobiopsy is a novel technique that increases the accuracy of diagnosing most pathologies that affect the mediastinum. Although EBUS-guided transbronchial needle aspiration (EBUS-TBNA) is the first choice in the diagnosis of mediastinal pathology, mediastinal cryobiopsy offers a larger and higher quality biopsy with minimal artifacts and no crushing when compared to conventional cytological samples obtained through EBUS-TBNA. It is particularly valuable in pathologies where EBUS-TBNA has diagnostic limitations, such as lymphoproliferative diseases, benign granulomatous conditions like sarcoidosis and silicosis, some rare infectious processes, metastases from rare non-pulmonary tumors, and in advanced stages of non-small cell lung cancer (NSCLC) where immunohistochemistry and molecular analysis are essential for personalized treatment. Therefore, mediastinal cryobiopsy seems to play a crucial role in these challenging scenarios. However, there is ongoing debate in the field of interventional pulmonology regarding the best approach for obtaining a mediastinal cryobiopsy. Some interventional pulmonologists use a high-frequency needle knife to create an incision in the tracheobronchial wall adjacent to the mediastinal lesion before inserting the cryoprobe, while others use a needle to create a pathway to the target area. There are also variations in the use of endoscopic or ultrasound imaging for guidance. In this article, we aim to review the current literature on different methods of performing mediastinal cryobiopsy and share our own clinical experience and methodology in a systematic way for its implementation in a safe, fast, and effective way.
RESUMEN
We can safely manage patients on antithrombotic therapy in the interventional pathology practice with this practical algorithm based on the new Antithrombotic Therapy Management Guidelines. This new algorithm helps ensure safe care for patients on antithrombotic therapy undergoing interventional pathology procedures. #interventionalpathology.
RESUMEN
INTRODUCTION: Despite the established role of the interventional pathologist, their diagnostic performance is difficult to establish. At least in Spain training of pathology residents in ultrasound-guided interventional procedures for specimen collection is limited or absent in most institutions. We present our teaching experience in the instruction of ultrasound-guided fine-needle aspiration (FNA) to pathology residents in a tertiary-level hospital. MATERIALS AND METHODS: The training of pathology residents who rotated through the interventional unit of the pathology department and the application of ultrasound-guided FNA and rapid on-site evaluation (U-ROSE) was documented over 5 years. The training period was broken down into learning phases and included the number of ultrasound-guided FNA performed, anatomical location, and their diagnostic performance, among other aspects. RESULTS: Nineteen (19) pathology residents were trained in U-ROSE, and performed a total of 4003 procedures, with a mean of 211 per resident. In 53% of cases only one pass was required for an adequated sample. The specimen was diagnostic in more than 97% of cases. The most frequently sampled anatomical sites were the thyroid gland (n = 2347), followed by lymph node (n = 667), soft tissues (n = 663) and salivary glands (n = 322). CONCLUSION: The results support the training programme followed by pathology residents in learning U-ROSE, which is essential to lay the foundations for the future interventional pathologist.
RESUMEN
ABSTRACT Sclerosing Mesenteritis (SM) is a rare diagnosis, particularly in pediatric patients, and is typically non-fatal when appropriately treated. Although molecular and immunohistochemical alterations have been described, no pathognomonic signature has been identified for this entity. This report presents a case of a seven-year-old boy who suffered sudden cardiorespiratory arrest. Upon autopsy, he was found to have multicentric SM on the upper mesentery, which led to bowel wall thinning and abdominal bleeding with bacterial translocation. We performed comprehensive morphological, immunohistochemical, and molecular analyses. SM is an atypical disorder with diverse clinical manifestations, including a rare but potentially fatal course. Early diagnosis is critical, given its potential severity. To our knowledge, this is the first case report of pediatric mortality linked to SM. Our findings emphasize the importance of increased awareness and early detection of SM in pediatric patients.
RESUMEN
Objetivo: Considerar el cáncer de próstatametastásico en el diagnóstico diferencial de masas mediastínicas. Métodos: Presentación de un caso clínico.Resultados: Se presenta el caso de un paciente varónde 78 años con diagnóstico de cáncer de próstata en elque se objetiva una masa mediastínica compatible conmetástasis prostática. Conclusion: El mediastino es un lugar muy infrecuentede metástasis de cáncer de próstata, pero hay que considerarlo en el diagnóstico diferencial de masas mediastínicas. El tratamiento es el estándar del cáncer de próstatametastásico.(AU)
Objetive: To assess the metastasic prostatecancer in the differenctial diagnosis of mediastinal masses. Methods: To report a case. Results: We present the case of a 78-year-old male patient with a diagnosis of prostate cancer with a mediastinalmass compatible with prostate metastasis. Conclusion: Mediastinum is a very rare site for prostate cancer metastasis, but it must be considered in thedifferential diagnosis of mediastinal masses. Treatment isthe usual for metastatic prostate cancer.(AU)
Asunto(s)
Humanos , Masculino , Anciano , Pacientes Internos , Examen Físico , Metástasis de la Neoplasia , Neoplasias de la Próstata , Mediastino , Diagnóstico , QuimioterapiaRESUMEN
No disponible
Asunto(s)
Humanos , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Neoplasias Pulmonares , Biopsia con Aguja , Lesión Pulmonar , Atelectasia Pulmonar , Pared Torácica , Tomografía Computarizada por Rayos XRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Neurilemoma/complicaciones , Neoplasias Pleurales/diagnóstico por imagen , Neoplasias Pleurales/patología , Carcinoma/secundario , Neoplasias del Recto/patología , Metástasis de la Neoplasia/patología , Tórax/diagnóstico por imagen , Tórax/patología , Biopsia , Inmunohistoquímica/métodos , Diagnóstico Diferencial , Mediastino/diagnóstico por imagen , Mediastino/patologíaRESUMEN
Introducción. El desarrollo y perfeccionamiento de la ecografía a partir de los setenta supuso un gran avance en el ámbito de la punción aspiración con aguja fina (PAAF), posibilitando localizar lesiones no palpables y minimizar complicaciones. El uso de PAAF ecoguiada trajo como consecuencia que dicha técnica se desplazara por motivos logísticos de los servicios de anatomía patológica a los servicios de radiología. El «alejamiento del patólogo» trajo como consecuencia numerosos inconvenientes. Con la finalidad de recuperar el territorio perdido y optimizar el procedimiento se inició una experiencia pionera y hasta donde sabemos única España en el Servicio de Anatomía Patológica del Hospital Universitario Central de Asturias (HUCA) con la PAAF ecoguiada realizada por citopatólogo. Método. Se cuantificaron todas las PAAF realizadas en el HUCA desde el 1 de julio de 2015 hasta el 30 de junio de 2016. Se procedió a clasificarlas dependiendo de si fueron PAAF ecoguiadas realizadas por patólogo o PAAF no realizada por patólogo, teniendo como principal criterio si fueron valorables o insuficientes. Resultados. Casi la mitad de las PAAF efectuadas fueron realizadas por citopatólogo (923). Las PAAF ecoguiadas realizadas por patólogo superaron en rendimiento diagnóstico a las PAAF no realizadas por patólogo. En todas las localizaciones anatómicas comprables, la PAAF ecoguiada realizada por patólogo tuvo un menor porcentaje de muestras insuficientes (4,33%) en comparación con la PAAF no realizada por patólogo (12,05%). Conclusión. El citopatólogo adecuadamente adiestrado es capaz de realiza PAAF ecoguiada con excelentes resultados. Los buenos resultados obtenidos han traído como consecuencia el aumento progresivo del número de PAAF solicitadas para llevar a cabo en el Servicio de Anatomía Patológica (AU)
Introduction. The development and improvement of ultrasound from the seventies has caused a breakthrough in fine needle aspiration (FNA), allowing the location of non-palpable lesions and minimizing complications. For logistic reasons, ultrasound-guided-FNA (US-FNA) is carried out in the department of radiology. However, the distance from the pathologist has many disadvantages. In order to correct this and thus optimize the procedure, the Department of Pathology at the University Hospital of Asturias (Hospital Universitario Central de Asturias [HUCA]) has initiated, for the first time in Spain, the Ultrasound-Guided-FNA Performed by Cytopathologists programme. We present our experience so far. Method. FNA performed at HUCA were quantified from July 1st 2015 to June 30th 2016. FNA were classified as US-FNA-cytopathologists or US-FNA-without cytopathologists. Criteria of sufficient and insufficient samples were taken into account. Results. Almost half of the FNA were made by cytopathologists (923). The performance of US-FNA-cytopathologists was better than US-FNA-without cytopathologists. US-FNA-cytopathologists had a lower percentage of inadequate samples (4.33%) compared to FNA carried out by non cytopathologists (12.05%). Conclusion. Adequately trained cytopathologists can perform US-FNA with excellent results. Our positive experience has resulted in an increase in the number of requests for FNA to be carried out in the Department of Pathology (AU)